Chemical inhibitors of the protein 1700001J03Rik can modulate its activity through various intracellular signaling pathways. Staurosporine, a well-known kinase inhibitor, can inhibit protein kinase C (PKC), which is involved in the phosphorylation and activation of numerous proteins, including 1700001J03Rik. Similarly, Bisindolylmaleimide I specifically targets PKC, leading to a decrease in the activation state of 1700001J03Rik by preventing its phosphorylation. LY294002 and Wortmannin serve as inhibitors of phosphoinositide 3-kinases (PI3K), which are upstream of AKT signaling pathways that can regulate the activity of 1700001J03Rik. The inhibition of PI3K by these chemicals suppresses AKT activation, which can then reduce the activity of 1700001J03Rik. PD98059 and U0126 are inhibitors of MEK1 and MEK2, components of the MAPK/ERK pathway, which also has a regulatory role in the function of 1700001J03Rik. By inhibiting MEK, the subsequent activation of ERK is decreased, which can lead to a reduction in 1700001J03Rik activity.
In addition to these inhibitors, SB203580 and SP600125 can affect 1700001J03Rik through different pathways. SB203580 is a selective inhibitor of p38 MAP kinase, a protein involved in responding to stress signals, which can regulate the function of 1700001J03Rik. SP600125 inhibits JNK, another kinase that modulates various cellular functions potentially regulated by 1700001J03Rik, leading to its functional inhibition. Rapamycin inhibits mTOR, a central regulator of cell growth and protein synthesis, and its inhibition can downregulate the function of 1700001J03Rik. PP2 targets Src family tyrosine kinases, which might phosphorylate 1700001J03Rik or its associated regulators, thus inhibiting its function. Dasatinib broadly inhibits BCR-ABL and Src family kinases, which can regulate the activity of 1700001J03Rik. Lastly, Y-27632 inhibits ROCK, a kinase that affects cell shape and motility, which can also lead to the inhibition of 1700001J03Rik's function. Each of these chemicals interacts with specific kinases or pathways to modulate the activity of 1700001J03Rik, illustrating the complex network of regulatory mechanisms that control protein function within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC, which 1700001J03Rik may interact with to modulate intracellular signaling. Inhibition of PKC can lead to reduced phosphorylation and activation of downstream targets that control the function of 1700001J03Rik. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits PKC, a kinase that can regulate the function of 1700001J03Rik via phosphorylation. Inhibition of PKC can result in diminished activation of 1700001J03Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which is upstream of AKT signaling, a pathway that may be involved in the regulation of 1700001J03Rik. Inhibition of PI3K can suppress AKT activation, potentially inhibiting the activity of 1700001J03Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, reducing AKT phosphorylation and activity. As PI3K/AKT signaling can control the function of 1700001J03Rik, its inhibition can lead to the functional inhibition of 1700001J03Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is part of the MAPK/ERK pathway, known to regulate various proteins, potentially including 1700001J03Rik. MEK inhibition results in decreased ERK activation and can inhibit the function of 1700001J03Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2, leading to reduced ERK pathway signaling. Suppression of this pathway can inhibit the function of proteins regulated by it, such as 1700001J03Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, which is involved in stress response signaling pathways. Inhibition of p38 MAP kinase can inhibit the function of 1700001J03Rik, should it be a downstream effector. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which modulates various cellular functions including those regulated by 1700001J03Rik. Inhibition of JNK can lead to the functional inhibition of 1700001J03Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which can downregulate protein synthesis and cell growth pathways that 1700001J03Rik may be part of. Inhibition of mTOR can lead to functional inhibition of 1700001J03Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases, which might phosphorylate 1700001J03Rik or its regulators. Inhibition of Src kinases can inhibit the function of 1700001J03Rik. | ||||||